Loading patent…
AssigneeRigel Pharmaceuticals, Inc.
InventorsDavid Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
Estimating the term…
The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the random peptides and random peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening random peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.
A library of fusion proteins each comprising:
A library of fusion proteins each comprising:
A library of fusion proteins each comprising:
A library of fusion proteins each comprising:
A library of fusion proteins, each comprising:
A library of fusion proteins, each comprising:
A library of fusion proteins, each comprising:
A library of fusion proteins, each comprising:
Dependencies are inferred from the claim text.